Dianwen Ju

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Enhanced Generalizability of RNA Secondary Structure Prediction via Convolutional Block Attention Network and Ensemble Learning.
  2025 L1 87/100

1 assessed by us (1 reproduced) · 189 not yet assessed — every PubMed paper on record, linked below.

• Integrative Transcriptomic Analysis Identifies COL3A1 as a Potential Tumor-Intrinsic Therapeutic Target in NSCLC ↗

  Biomedicines · 2026 · PMID 42193303
  not yet assessed
• Anti-ANGPTL3 antibody and IL-22 fusion protein mitigate nephrotic syndrome via mitochondrial protection, anti-apoptosis, and autophagy suppression ↗

  Antibody Therapeutics · 2026
  not yet assessed
• Preclinical profiling of a humanized anti-CD47 antibody that safely unleashes macrophage-mediated antitumor immunity ↗

  SSRN Electronic Journal · 2026
  not yet assessed
• Targeting ANGPTL3 and IL‐33/ST2 Ameliorates Diabetic Kidney Disease by Reducing Lipotoxicity, Alleviating Inflammation and Inhibiting Fibrosis ↗

  Advanced Science · 2026 · PMID 42153991
  not yet assessed
• Nanobody-engineered bispecific IL-18 mimetics drive antitumor immunity by engaging CD8+ T cell and evading IL-18BP in preclinical models ↗

  Molecular Therapy · 2025 · PMID 40676834
  not yet assessed
• Enhancing catalytic efficiency of two microbial uricases making by directed evolution ↗

  International Journal of Biological Macromolecules · 2025 · PMID 39892538
  not yet assessed
• A Hyperbolic Discrete Diffusion 3D RNA Inverse Folding Model for Functional RNA Design ↗

  Journal of Chemical Information and Modeling · 2025 · PMID 40503717
  not yet assessed
• DDR1 Drives Collagen Remodeling and Immune Exclusion: Pan-Cancer Insights and Therapeutic Targeting in Pancreatic Ductal Adenocarcinoma ↗

  International Journal of Molecular Sciences · 2025 · PMID 40869052
  not yet assessed
• NPASS database update 2026: comprehensive quantitative composition, bioactivity, and ADME-Tox data of natural products for biomedical research ↗

  Nucleic Acids Research · 2025 · PMID 41243954
  not yet assessed
• Rubicon siRNA-encapsulated liver-targeting nanoliposome is a promising therapeutic for non-alcoholic fatty liver disease ↗

  International Journal of Pharmaceutics · 2025 · PMID 39880145
  not yet assessed
• IL-2-loaded liposomes modified with sorafenib derivative exert a synergistic anti-melanoma effect via improving tumor immune microenvironment and enhancing antiangiogenic activity ↗

  Asian Journal of Pharmaceutical Sciences · 2025 · PMID 40475279
  not yet assessed
• Recombinant CD80 fusion protein combined with discoidin domain receptor 1 inhibitor for cancer treatment ↗

  Applied Microbiology and Biotechnology · 2025 · PMID 39918582
  not yet assessed
• Development of an anti-LAIR1 antibody-drug conjugate for acute myeloid leukemia therapy ↗

  International Journal of Biological Macromolecules · 2025 · PMID 39753170
  not yet assessed
• Rational Design of Site-Specific Fatty Acid Derivatives to Extend the Half-Life of Fibroblast Growth Factor 21 ↗

  Bioconjugate Chemistry · 2025 · PMID 40085485
  not yet assessed
• TargetPair: A Single Cell-omics Resource of Clinical Trials-derived Therapeutical Target Combinations for Cancer Therapy ↗

  Journal of Molecular Biology · 2025 · PMID 40840587
  not yet assessed
• Improved biodistribution and antitumor effects of a Nectin4 and Trop2 bispecific fatty acid-modified nanobody conjugate ↗

  Journal of Controlled Release · 2025 · PMID 41101697
  not yet assessed
• A Hyperbolic Discrete Diffusion 3D RNA Inverse Folding Model for functional RNA design ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2025
  not yet assessed
• Chemical Structure-based Graph Convolutional Model for Drug-Gut Microbiota Association Prediction ↗

  Chemical Research in Chinese Universities · 2025
  not yet assessed
• Enhanced Generalizability of RNA Secondary Structure Prediction via Convolutional Block Attention Network and Ensemble Learning

  Molecules · 2025 · PMID 40871599
  L1 87/100
• Targeting angiopoietin-like protein 3 and Interleukin-1β alleviated liver and kidney injury through attenuation of lipotoxicity and normalization of glycolipid metabolism in db/db mice ↗

  Research Square · 2025
  not yet assessed
• MASI2.0: Insights of Microbiota Metabolic Potential from Incorporating Genomic Information on Microbiota-Active Substance Interactions ↗

  Journal of Molecular Biology · 2025 · PMID 41412488
  not yet assessed
• Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer ↗

  Biomedicine & Pharmacotherapy · 2024 · PMID 39418963
  not yet assessed
• Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era ↗

  Biomedicines · 2024 · PMID 38255298
  not yet assessed
• Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer ↗

  Cell Death Discovery · 2024 · PMID 39227365
  not yet assessed
• Natural killer cell engagers: From bi‐specific to tri‐specific and tetra‐specific engagers for enhanced cancer immunotherapy ↗

  Clinical and Translational Medicine · 2024 · PMID 39472273
  not yet assessed
• A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE ↗

  Cell Death and Disease · 2024 · PMID 38664366
  not yet assessed
• Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy ↗

  Journal for ImmunoTherapy of Cancer · 2024 · PMID 39231544
  not yet assessed
• Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer ↗

  Cancer Immunology Immunotherapy · 2024 · PMID 38532108
  not yet assessed
• Simultaneously blocking ANGPTL3 and CD47 prevents the progression of atherosclerosis through regulating lipid metabolism, macrophagic efferocytosis and lipid peroxidation ↗

  Pharmacological Research · 2024 · PMID 39488258
  not yet assessed
• Lipid Nanoparticle‐Mediated Delivery of CRISPR‐Cas9 Against Rubicon Ameliorates NAFLD by Modulating CD36 Along with Glycerophospholipid Metabolism ↗

  Advanced Science · 2024 · PMID 38894572
  not yet assessed
• A Novel Bifunctional Fusion Protein (Anti-IL-17A-sST2) Protects against Acute Liver Failure, Modulating the TLR4/MyD88 Pathway and NLRP3 Inflammasome Activation ↗

  Biomedicines · 2024 · PMID 38791080
  not yet assessed
• 1265P A promising MET-EGFR bispecific nanobody-drug conjugate therapy for multiple solid tumours ↗

  Annals of Oncology · 2024
  not yet assessed
• Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer ↗

  Biomedicines · 2024 · PMID 39335665
  not yet assessed
• Simultaneously blocking ANGPTL3 and IL-1β for the treatment of atherosclerosis through lipid-lowering and anti-inflammation ↗

  Inflammation Research · 2024 · PMID 39254873
  not yet assessed
• Dose escalation of KY-0118, PD-1, and IL-2v due-target fusion protein in patients with advanced renal clear cell carcinoma, urothelial carcinoma, and malignant melanoma. ↗

  Journal of Clinical Oncology · 2024
  not yet assessed
• Prediction of human gut microbiota-drug associations based on multiple graph convolutional networks ↗

  Bioinformatics Advances · 2024
  not yet assessed
• TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer ↗

  Journal of Nanobiotechnology · 2023 · PMID 37932752
  not yet assessed
• Research progress of interleukin-15 in cancer immunotherapy ↗

  Frontiers in Pharmacology · 2023 · PMID 37251333
  not yet assessed
• Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles ↗

  Biomaterials · 2023 · PMID 37988899
  not yet assessed
• CMAUP database update 2024: extended functional and association information of useful plants for biomedical research ↗

  Nucleic Acids Research · 2023 · PMID 37897343
  not yet assessed
• Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response ↗

  Cell Death Discovery · 2023 · PMID 36646672
  not yet assessed
• Inhibition of Hedgehog signaling ameliorates foam cell formation by promoting autophagy in early atherosclerosis ↗

  Cell Death and Disease · 2023 · PMID 37963874
  not yet assessed
• Innate Immunity in Cancer Biology and Therapy ↗

  International Journal of Molecular Sciences · 2023 · PMID 37510993
  not yet assessed
• Vunakizumab-IL22, a Novel Fusion Protein, Promotes Intestinal Epithelial Repair and Protects against Gut Injury Induced by the Influenza Virus ↗

  Biomedicines · 2023 · PMID 37189778
  not yet assessed
• Risk control of host cell proteins in one therapeutic antibody produced by concentrated fed‐batch (CFB) mode ↗

  Engineering in Life Sciences · 2023 · PMID 36874608
  not yet assessed
• Targeting CD47 Enhanced the Antitumor Immunity of PD-L1 Blockade in B-Cell Lymphoma ↗

  Immunotherapy · 2023 · PMID 36727256
  not yet assessed
• A bifunctional fusion protein protected against diabetic nephropathy by suppressing NLRP3 activation ↗

  Applied Microbiology and Biotechnology · 2023 · PMID 36843198
  not yet assessed
• Correction: Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer ↗

  Cell Death and Disease · 2023 · PMID 37752104
  not yet assessed
• Co-targeting CD47 and VEGF Elicited Potent Antitumor Effects in Gastric Cancer ↗

  Research Square · 2023
  not yet assessed
• Supplementary Figures 1 through 12 from Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer ↗

  2023
  not yet assessed
• Data from Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer ↗

  2023
  not yet assessed
• Supplementary Figures 1 through 12 from Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer ↗

  2023
  not yet assessed
• Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies ↗

  Frontiers in Immunology · 2023 · PMID 37638039
  not yet assessed
• Editorial: Community series in combinational immunotherapy of cancer: novel targets, mechanisms, and strategies, volume II ↗

  Frontiers in Immunology · 2023 · PMID 37638018
  not yet assessed
• Data from Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer ↗

  2023
  not yet assessed
• The role of interleukin-22 in lung health and its therapeutic potential for COVID-19 ↗

  Frontiers in Immunology · 2022 · PMID 35967401
  not yet assessed
• GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis ↗

  Frontiers in Immunology · 2022 · PMID 36217543
  not yet assessed
• Cell Membrane-Derived Vesicle: A Novel Vehicle for Cancer Immunotherapy ↗

  Frontiers in Immunology · 2022 · PMID 35874757
  not yet assessed
• A novel nanobody-heavy chain antibody against Angiopoietin-like protein 3 reduces plasma lipids and relieves nonalcoholic fatty liver disease ↗

  Journal of Nanobiotechnology · 2022 · PMID 35590366
  not yet assessed
• A SIRPαFc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer ↗

  Frontiers in Immunology · 2022 · PMID 35422796
  not yet assessed
• Synergistic anticancer effect of flavonoids from <i>Sophora alopecuroides</i> with Sorafenib against hepatocellular carcinoma ↗

  Phytotherapy Research · 2022 · PMID 36180975
  not yet assessed
• Interleukin-22 in Renal Protection and Its Pathological Role in Kidney Diseases ↗

  Frontiers in Immunology · 2022 · PMID 35432360
  not yet assessed
• A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice ↗

  Frontiers in Immunology · 2022 · PMID 36544775
  not yet assessed
• Targeting 4-1BB and PD-L1 induces potent and durable antitumor immunity in B-cell lymphoma ↗

  Frontiers in Immunology · 2022 · PMID 36544785
  not yet assessed
• Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer ↗

  Antibody Therapeutics · 2022 · PMID 35372786
  not yet assessed
• Development of a bridging ELISA for detection of antibodies against ZV0203 in cynomolgus monkey serum ↗

  Journal of Pharmacological and Toxicological Methods · 2022 · PMID 36028046
  not yet assessed
• Characterization of light chain c-terminal extension sequence variant in one bispecific antibody ↗

  Frontiers in Chemistry · 2022 · PMID 36204149
  not yet assessed
• A Novel Nanobody-Heavy Chain Antibody Against Angiopoietin-Like Protein 3 Reduces Plasma Lipids and Relieves Nonalcoholic Fatty Liver Disease ↗

  Research Square · 2022
  not yet assessed
• Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)¹ ↗

  Autophagy · 2021 · PMID 33634751
  not yet assessed
• IL‐22‐mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury ↗

  Clinical and Translational Medicine · 2021 · PMID 33634980
  not yet assessed
• Amino Acid Degrading Enzymes and Autophagy in Cancer Therapy ↗

  Frontiers in Pharmacology · 2021 · PMID 33510635
  not yet assessed
• Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer ↗

  Cell Death and Disease · 2021 · PMID 33731670
  not yet assessed
• Design, synthesis and biological evaluation of double fatty chain-modified glucagon-like peptide-1 conjugates ↗

  Bioorganic & Medicinal Chemistry · 2021 · PMID 34216986
  not yet assessed
• A Novel Bifunctional Fusion Protein, Vunakizumab-IL22, for Protection Against Pulmonary Immune Injury Caused by Influenza Virus ↗

  Frontiers in Immunology · 2021 · PMID 34504501
  not yet assessed
• Synthesis and Antitumor Activity of (3-Hydroxyacrylato-O,O′) Diammineplatinum(II) ↗

  Pharmaceutical Fronts · 2021
  not yet assessed
• CCDC 2042889: Experimental Crystal Structure Determination ↗

  The Cambridge Structural Database · 2021
  not yet assessed
• Gene therapy for neurodegenerative disorders: advances, insights and prospects ↗

  Acta Pharmaceutica Sinica B · 2020 · PMID 32963936
  not yet assessed
• Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment ↗

  Acta Pharmaceutica Sinica B · 2020 · PMID 33777671
  not yet assessed
• VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses ↗

  Acta Pharmaceutica Sinica B · 2020 · PMID 33532185
  not yet assessed
• Construction of paclitaxel-based antibody–drug conjugates with a PEGylated linker to achieve superior therapeutic index ↗

  Signal Transduction and Targeted Therapy · 2020 · PMID 32728048
  not yet assessed
• MASI: microbiota—active substance interactions database ↗

  Nucleic Acids Research · 2020 · PMID 33125077
  not yet assessed
• Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury ↗

  Theranostics · 2020 · PMID 32483425
  not yet assessed
• The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells ↗

  AMB Express · 2020 · PMID 32495214
  not yet assessed
• An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases ↗

  Frontiers in Immunology · 2020 · PMID 33329588
  not yet assessed
• Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy ↗

  Bioorganic & Medicinal Chemistry Letters · 2020 · PMID 32088128
  not yet assessed
• Toxicity of polymeric nanomaterials ↗

  Elsevier eBooks · 2020
  not yet assessed
• Synergistic Antitumor Effect of 5-Fluorouracil Combined with Constituents from Pleurospermum lindleyanum in Hepatocellular Carcinoma SMMC-7721 Cells ↗

  Anti-Cancer Agents in Medicinal Chemistry · 2020 · PMID 32838723
  not yet assessed
• Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors ↗

  Anti-Cancer Agents in Medicinal Chemistry · 2020 · PMID 32496990
  not yet assessed
• Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) ↗

  UNC Libraries · 2020
  not yet assessed
• Application of Nanomaterials for Cancer Diagnosis and Therapy ↗

  2020
  not yet assessed
• Interleukin-22 drives a metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2020
  not yet assessed
• Interleukin-22 mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2020
  not yet assessed
• List of Contributors ↗

  Elsevier eBooks · 2020
  not yet assessed
• Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer ↗

  Journal for ImmunoTherapy of Cancer · 2019 · PMID 31829270
  not yet assessed
• Large-scale microcarrier culture of HEK293T cells and Vero cells in single-use bioreactors ↗

  AMB Express · 2019 · PMID 31127400
  not yet assessed
• Plasma MicroRNA Pair Panels as Novel Biomarkers for Detection of Early Stage Breast Cancer ↗

  Frontiers in Physiology · 2019 · PMID 30670982
  not yet assessed
• Enhancement of FK520 production in Streptomyces hygroscopicus by combining traditional mutagenesis with metabolic engineering ↗

  Applied Microbiology and Biotechnology · 2019 · PMID 31713669
  not yet assessed
• Blocking the PD-1-PD-L1 axis by a novel PD-1 specific nanobody expressed in yeast as a potential therapeutic for immunotherapy ↗

  Biochemical and Biophysical Research Communications · 2019 · PMID 31495493
  not yet assessed
• Regulating autophagy facilitated therapeutic efficacy of the sonic Hedgehog pathway inhibition on lung adenocarcinoma through GLI2 suppression and ROS production ↗

  Cell Death and Disease · 2019 · PMID 31427566
  not yet assessed
• Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 Inflammasome ↗

  Frontiers in Immunology · 2019 · PMID 31616439
  not yet assessed
• GSDMD membrane pore is critical for IL-1β release and antagonizing IL-1β by hepatocyte-specific nanobiologics is a promising therapeutics for murine alcoholic steatohepatitis ↗

  Biomaterials · 2019 · PMID 31670032
  not yet assessed
• Enhancement of ascomycin production via a combination of atmospheric and room temperature plasma mutagenesis in Streptomyces hygroscopicus and medium optimization ↗

  AMB Express · 2019 · PMID 30778695
  not yet assessed
• Recombinant human arginase I elicited immunosuppression in activated macrophages through inhibiting autophagy ↗

  Applied Microbiology and Biotechnology · 2019 · PMID 31053913
  not yet assessed
• Recent Advances on Carbonyl Reductases for Dynamic Kinetic Resolution ↗

  Chinese Journal of Organic Chemistry · 2019
  not yet assessed
• Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome ↗

  Phytomedicine · 2018 · PMID 29519318
  not yet assessed
• NOD-Like Receptor Protein 3 Inflammasome-Dependent IL-1β Accelerated ConA-Induced Hepatitis ↗

  Frontiers in Immunology · 2018 · PMID 29692782
  not yet assessed
• Mesoporous silica nanoparticles induced hepatotoxicity <i>via</i> NLRP3 inflammasome activation and caspase-1-dependent pyroptosis ↗

  Nanoscale · 2018 · PMID 29722780
  not yet assessed
• Hedgehog Signaling Pathway and Autophagy in Cancer ↗

  International Journal of Molecular Sciences · 2018 · PMID 30081498
  not yet assessed
• Inflammasome: A Double-Edged Sword in Liver Diseases ↗

  Frontiers in Immunology · 2018 · PMID 30319645
  not yet assessed
• The Role of Autophagy in Nanoparticles-Induced Toxicity and Its Related Cellular and Molecular Mechanisms ↗

  Advances in experimental medicine and biology · 2018 · PMID 29453533
  not yet assessed
• Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma ↗

  Carcinogenesis · 2018 · PMID 29538621
  not yet assessed
• Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma ↗

  Applied Microbiology and Biotechnology · 2018 · PMID 29754163
  not yet assessed
• Insights into CD47/SIRPα axis-targeting tumor immunotherapy ↗

  Antibody Therapeutics · 2018 · PMID 34056543
  not yet assessed
• In vivo hepatocellular expression of interleukin-22 using penetratin-based hybrid nanoparticles as potential anti-hepatitis therapeutics ↗

  Biomaterials · 2018 · PMID 30296739
  not yet assessed
• Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E ↗

  Frontiers in Immunology · 2018 · PMID 30123222
  not yet assessed
• Neurotoxicity concern about the brain targeting delivery systems ↗

  Elsevier eBooks · 2018
  not yet assessed
• Contributors ↗

  Elsevier eBooks · 2018
  not yet assessed
• Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer ↗

  Cancer Immunology Research · 2017 · PMID 28351890
  not yet assessed
• Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation ↗

  Cell Death and Disease · 2017 · PMID 28726774
  not yet assessed
• A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor ↗

  Cell Death and Disease · 2017 · PMID 28358368
  not yet assessed
• Blocking autophagy improves the anti-tumor activity of afatinib in lung adenocarcinoma with activating EGFR mutations in vitro and in vivo ↗

  Scientific Reports · 2017 · PMID 28676644
  not yet assessed
• The role of autophagy in asparaginase-induced immune suppression of macrophages ↗

  Cell Death and Disease · 2017 · PMID 28358370
  not yet assessed
• Deprivation of asparagine triggers cytoprotective autophagy in laryngeal squamous cell carcinoma ↗

  Applied Microbiology and Biotechnology · 2017 · PMID 28352997
  not yet assessed
• Autophagy suppression potentiates the anti-glioblastoma effect of asparaginase <i>in vitro</i> and <i>in vivo</i> ↗

  Oncotarget · 2017 · PMID 29207624
  not yet assessed
• Targeting TNFα Ameliorated Cationic PAMAM Dendrimer-Induced Hepatotoxicity via Regulating NLRP3 Inflammasomes Pathway ↗

  ACS Biomaterials Science & Engineering · 2017 · PMID 33440489
  not yet assessed
• Novel and promising therapeutic approaches for glioblastoma: Blocking CD47-SIRPα axis alone or combined with autophagy depletion ↗

  Annals of Oncology · 2017
  not yet assessed
• Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) ↗

  Autophagy · 2016 · PMID 26799652
  not yet assessed
• Diosgenin induces ROS-dependent autophagy and cytotoxicity via mTOR signaling pathway in chronic myeloid leukemia cells ↗

  Phytomedicine · 2016 · PMID 26969378
  not yet assessed
• Targeting asparagine and autophagy for pulmonary adenocarcinoma therapy ↗

  Applied Microbiology and Biotechnology · 2016 · PMID 27251546
  not yet assessed
• Phosphorylated Peptide Functionalization of Lanthanide Upconversion Nanoparticles for Tuning Nanomaterial–Cell Interactions ↗

  ACS Applied Materials & Interfaces · 2016 · PMID 26927957
  not yet assessed
• The Application, Neurotoxicity, and Related Mechanism of Cationic Polymers∗∗Conflict of Interests: All the Figures and Table in “The application, neurotoxicity, and related mechanism of cationic polymers” are original, unpublished materials designed and prepared by Yubin Li and Dianwen Ju. The authors declared that there’s no conflict of interests. ↗

  Elsevier eBooks · 2016
  not yet assessed
• 399P Blocking CD47 and autophagy for the therapy of non-small-cell lung cancer ↗

  Annals of Oncology · 2016
  not yet assessed
• Inhibition of autophagy protects against PAMAM dendrimers-induced hepatotoxicity ↗

  Figshare · 2016
  not yet assessed
• Asparaginase induces apoptosis and cytoprotective autophagy in chronic myeloid leukemia cells ↗

  Oncotarget · 2015 · PMID 25738356
  not yet assessed
• Inhibition of autophagy overcomes the nanotoxicity elicited by cadmium-based quantum dots ↗

  Biomaterials · 2015 · PMID 26686052
  not yet assessed
• Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia ↗

  Autophagy · 2015 · PMID 25701353
  not yet assessed
• Interplay of Oxidative Stress and Autophagy in PAMAM Dendrimers-Induced Neuronal Cell Death ↗

  Theranostics · 2015 · PMID 26516373
  not yet assessed
• The role of autophagy in the cytotoxicity induced by recombinant human arginase in laryngeal squamous cell carcinoma ↗

  Applied Microbiology and Biotechnology · 2015 · PMID 25904129
  not yet assessed
• Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells ↗

  PLoS ONE · 2015 · PMID 26288183
  not yet assessed
• Blocking autophagy enhanced leukemia cell death induced by recombinant human arginase ↗

  Tumor Biology · 2015 · PMID 26643895
  not yet assessed
• A novel therapeutic approach against B-cell non-Hodgkin’s lymphoma through co-inhibition of Hedgehog signaling pathway and autophagy ↗

  Tumor Biology · 2015 · PMID 26666826
  not yet assessed
• A novel approach to overcome non-small-cell lung cancer: co-inhibition of autophagy and Hedgehog pathway ↗

  Annals of Oncology · 2015
  not yet assessed
• The role of autophagy in the neurotoxicity of cationic PAMAM dendrimers ↗

  Biomaterials · 2014 · PMID 24906346
  not yet assessed
• Anti-Inflammatory Effect of Thalidomide on H1N1 Influenza Virus-Induced Pulmonary Injury in Mice ↗

  Inflammation · 2014 · PMID 24912813
  not yet assessed
• Qiangzhi Decoction (羌跖汤) protects mice from influenza A pneumonia through inhibition of inflammatory cytokine storm ↗

  Chinese Journal of Integrative Medicine · 2014 · PMID 25519444
  not yet assessed
• Baicalin inhibits autophagy induced by influenza A virus H3N2 ↗

  Antiviral Research · 2014 · PMID 25446340
  not yet assessed
• Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells ↗

  Cell Death and Disease · 2014 · PMID 25501824
  not yet assessed
• Long-term biodistribution in vivo and toxicity of radioactive/magnetic hydroxyapatite nanorods ↗

  Biomaterials · 2014 · PMID 24439404
  not yet assessed
• Inhibition of autophagy protects against PAMAM dendrimers-induced hepatotoxicity ↗

  Nanotoxicology · 2014 · PMID 24983897
  not yet assessed
• Cationic poly(amidoamine) dendrimers induced cyto-protective autophagy in hepatocellular carcinoma cells ↗

  Nanotechnology · 2014 · PMID 25140534
  not yet assessed
• Tyrosine kinase inhibitor Thiotanib targets Bcr-Abl and induces apoptosis and autophagy in human chronic myeloid leukemia cells ↗

  Applied Microbiology and Biotechnology · 2014 · PMID 25200837
  not yet assessed
• Ability of Recombinant Human Catalase to Suppress Inflammation of the Murine Lung Induced by Influenza A ↗

  Inflammation · 2014 · PMID 24385240
  not yet assessed
• Synthesis of novel 10-hydroxycamptothecin derivatives utilizing topotecan hydrochloride as ortho-quinonemethide precursor ↗

  Bioorganic & Medicinal Chemistry · 2014 · PMID 25481395
  not yet assessed
• Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice ↗

  Critical Care · 2013 · PMID 24373231
  not yet assessed
• Suppression of Autophagy Enhanced Growth Inhibition and Apoptosis of Interferon-β in Human Glioma Cells ↗

  Molecular Neurobiology · 2013 · PMID 23329343
  not yet assessed
• Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin’s lymphoma cells ↗

  Cell Death and Disease · 2013 · PMID 24113174
  not yet assessed
• Modified Jiu Wei Qiang Huo decoction improves dysfunctional metabolomics in influenza A pneumonia‐infected mice ↗

  Biomedical Chromatography · 2013 · PMID 24132661
  not yet assessed
• PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice ↗

  Applied Microbiology and Biotechnology · 2013 · PMID 23525936
  not yet assessed
• Involvement of autophagy in recombinant human arginase-induced cell apoptosis and growth inhibition of malignant melanoma cells ↗

  Applied Microbiology and Biotechnology · 2013 · PMID 23917632
  not yet assessed
• Autophagy Plays a Critical Role in ChLym-1-Induced Cytotoxicity of Non-Hodgkin’s Lymphoma Cells ↗

  PLoS ONE · 2013 · PMID 24015249
  not yet assessed
• Pharmacokinetics and Pharmacodynamics of Recombinant Human EPO-Fc Fusion Protein In Vivo ↗

  PLoS ONE · 2013 · PMID 23977338
  not yet assessed
• High expression of recombinant human catalase and its immunomodulatory effects on H1N1 influenza virus infection ↗

  Process Biochemistry · 2013
  not yet assessed
• Tumor necrosis therapy antibody interleukin-2 fusion protein elicits prolonged and targeted antitumor effects in vivo ↗

  Applied Microbiology and Biotechnology · 2013 · PMID 24276620
  not yet assessed
• Roles of autophagy in doxorubicin-induced apoptosis of lymphoma cells ↗

  Academic Journal of Second Military Medical University · 2013
  not yet assessed
• Biotransformation pathways of ginsenoside Rb1 to compound K by β-glucosidases in fungus Paecilomyces Bainier sp. 229 ↗

  Process Biochemistry · 2010
  not yet assessed
• Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice ↗

  Cytokine · 2010 · PMID 20427198
  not yet assessed
• Therapeutic Effect of Recombinant Human Catalase on H1N1 Influenza-induced Pneumonia in Mice ↗

  Inflammation · 2009 · PMID 19957025
  not yet assessed
• Immunogenicity of Iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients ↗

  Cancer Immunology Immunotherapy · 2007 · PMID 17934732
  not yet assessed
• Dosimetry of chimeric TNT in lung tumor patients ↗

  Nuclear Science and Techniques · 2007
  not yet assessed
• Systemic genetic transfer of p21WAF−1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex ↗

  Cancer Gene Therapy · 2003 · PMID 12833133
  not yet assessed
• Adenovirus-mediated combined P16 gene and GM-CSF gene therapy for the treatment of established tumor and induction of antitumor immunity ↗

  Cancer Gene Therapy · 2002 · PMID 12224022
  not yet assessed
• Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer ↗

  Journal of Molecular Medicine · 2002 · PMID 12226740
  not yet assessed
• Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway ↗

  Immunology Letters · 2001 · PMID 11306142
  not yet assessed
• Vaccination with IL-18 gene-modified, superantigen-coated tumor cells elicits potent antitumor immune response ↗

  Journal of Cancer Research and Clinical Oncology · 2001 · PMID 11768611
  not yet assessed
• Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity ↗

  Gene Therapy · 2000 · PMID 11083476
  not yet assessed
• Adenovirus-mediated lymphotactin gene transfer improves therapeutic efficacy of cytosine deaminase suicide gene therapy in established murine colon carcinoma ↗

  Gene Therapy · 2000 · PMID 10694814
  not yet assessed
• [Antitumor effect of combined therapy with adenovirus-mediated CD suicide gene and interleukin 2 gene transfer and its immunological mechanism]. ↗

  PubMed · 1998 · PMID 10920957
  not yet assessed
• Efficient activation of antitumor immunity by IL-6 gene-modified leukemia vaccine in combination with low dose cyclophosphamide and low dose IL-2 ↗

  Chinese Journal of Cancer Research · 1998
  not yet assessed
• Enhanced antitumor effects of suicide gene therapy by simultaneous transfer of GM-CSF gene in leukemia-bearing mice ↗

  Chinese Journal of Cancer Research · 1998
  not yet assessed
• Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model. ↗

  PubMed · 1997 · PMID 9080123
  not yet assessed
• In vivo gene therapy of murine melanoma mediated by recombinant vaccinia virus encoding human IL-2 gene ↗

  International Journal of Oncology · 1997 · PMID 21533434
  not yet assessed
• Effects of granulocyte-macrophage colony stimulating factor gene encoded vaccinia virus vector on murine pulmonary metastatic melanoma ↗

  Chinese Journal of Cancer Research · 1997
  not yet assessed
• Anti-metastatic effect of oncolysates from murine melanoma cells transfected with recombinant vaccinia virus encoding human IL-2 ↗

  Chinese Journal of Cancer Research · 1997
  not yet assessed
• Effects of triazolodiazepine on the production of interleukin‐6 from murine spleen cells and rabbit synovial cells <i>in vitro</i> ↗

  Mediators of Inflammation · 1995 · PMID 18475629
  not yet assessed
• Protective effect of Phytolacca acinosa polysaccharides I (PAP-I) on hematopoiesis in cyclophosphamide-treated and ~(6))Co-irradiated mice

  Journal of Chinese Pharmaceutical Sciences · 1995
  not yet assessed
• Leflunomide inhibits cytokine-induced DNA synthesis of rabbit synovial cells in culture. ↗

  PubMed · 1994 · PMID 7976375
  not yet assessed
• Inhibitory effects of triazolodiazepine on mouse splenocytes and peritoneal macrophages in vitro. ↗

  PubMed · 1994 · PMID 8010089
  not yet assessed
• Effects of Phytolacca acinosa polysaccharides I on immune function in mice. ↗

  PubMed · 1993 · PMID 8237401
  not yet assessed
• Dauricine and anisodamine inhibited leukotrienes- and platelet activating factor-induced DNA synthesis and proliferation of bovine cerebral microvascular smooth muscle cells in culture. ↗

  PubMed · 1993 · PMID 8249627
  not yet assessed
• [Effects of platelet activating factor on the cerebrovascular permeability in rats and the protection by drug]. ↗

  PubMed · 1992 · PMID 1293934
  not yet assessed